Phosphodiesterase (PDE)4 inhibitors: anti-inflammatory drugs of the future?

Author： Teixeira M.M.   Gristwood R.W.   Cooper N.   Hellewell P.G.  

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.18, Iss.5, 1997-05, pp. : 164-170

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Advances in PDE4 Inhibitors as Immunoregulators and Anti- Inflammatory Drugs

By  

Current Pharmaceutical Design, Vol. 8, Iss. 14, 2002-06 ,pp. : 1255-1296

Bentham Science Publishers

Access to resources Recommend Favorite

Phosphodiesterase 4 (PDE4) Inhibitors in the Treatment of COPD: Promising Drug Candidates and Future Directions

By  

Current Medicinal Chemistry, Vol. 23, Iss. 2, 2016-01 ,pp. : 129-141

Bentham Science Publishers

Access to resources Recommend Favorite

Tryptase inhibitors: a novel class of anti-inflammatory drugs

By Numerof R.P.   Simpson P.J.   Tanaka R.  

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 7, 1997-07 ,pp. : 811-818

Informa Healthcare

Access to resources Recommend Favorite

Inhibitors of TACE and Caspase-1 As Anti-inflammatory Drugs

By  

Current Medicinal Chemistry, Vol. 12, Iss. 25, 2005-12 ,pp. : 2963-2977

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-inflammatory and bronchodilator properties of KF19514, a phosphodiesterase 4 and 1 inhibitor

By Manabe H.   Akuta K.   Sejimo H.   Kawasaki H.   Nukui E.   Ichimura M.   Kase H.   Kawakita T.   Suzuki F.   Kitamura S.   Sato S.   Ohmori K.  

European Journal of Pharmacology, Vol. 332, Iss. 1, 1997-07 ,pp. : 97-107

Elsevier

Access to resources Recommend Favorite